A Post-Marketing Clinical Study of Aricept in Patients With Dementia With Lewy Bodies (DLB)

NCT02345213 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Dementia, Lewy Body
Lewy Body Disease

Interventions

DRUG: E2020
DRUG: Placebo

Sponsor

Eisai Co., Ltd.